Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oliver

Showing results (481-490 of 519) with videos related to

Pageof 52
Sort By:
Lancet (London, England)|July 31, 1971
International collaboration in renal transplantationJ A Sachs, R T Oliver, H Festenstein, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyS D Fosså, R T Oliver, S P Stenning, et al.
Cancer|October 8, 1998
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working PartyS P Stenning, M C Parkinson, C Fisher, et al.
Gene|April 2, 2016
Transcriptome differences in the rumen of beef steers with variation in feed intake and gainRebecca J Kern, Amanda K Lindholm-Perry, Harvey C Freetly, et al.
Biology of Reproduction|August 14, 2018
Energy balance affects pulsatile secretion of luteinizing hormone from the adenohypophesis and expression of neurokinin B in the hypothalamus of ovariectomized giltsJennifer F Thorson, Ligia D Prezotto, Hillary Adams, et al.
Clinical and Experimental Immunology|May 11, 2018
HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cellsN E James, E Cantillo, M T Oliver, et al.
Frontiers in Pharmacology|April 4, 2019
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6Nicole E James, Matthew T Oliver, Jennifer R Ribeiro, et al.
Scientific Reports|May 24, 2020
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genesNicole E James, Jenna B Emerson, Ashley D Borgstadt, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working PartyG M Duchesne, S P Stenning, N Aass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer TrialA Horwich, D T Sleijfer, S D Fosså, et al.
Pageof 52

Showing results (481-490 of 519) with videos related to

Sort By:
Pageof 52
Lancet (London, England)|July 31, 1971
International collaboration in renal transplantationJ A Sachs, R T Oliver, H Festenstein, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyS D Fosså, R T Oliver, S P Stenning, et al.
Cancer|October 8, 1998
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working PartyS P Stenning, M C Parkinson, C Fisher, et al.
Gene|April 2, 2016
Transcriptome differences in the rumen of beef steers with variation in feed intake and gainRebecca J Kern, Amanda K Lindholm-Perry, Harvey C Freetly, et al.
Biology of Reproduction|August 14, 2018
Energy balance affects pulsatile secretion of luteinizing hormone from the adenohypophesis and expression of neurokinin B in the hypothalamus of ovariectomized giltsJennifer F Thorson, Ligia D Prezotto, Hillary Adams, et al.
Clinical and Experimental Immunology|May 11, 2018
HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cellsN E James, E Cantillo, M T Oliver, et al.
Frontiers in Pharmacology|April 4, 2019
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6Nicole E James, Matthew T Oliver, Jennifer R Ribeiro, et al.
Scientific Reports|May 24, 2020
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genesNicole E James, Jenna B Emerson, Ashley D Borgstadt, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working PartyG M Duchesne, S P Stenning, N Aass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer TrialA Horwich, D T Sleijfer, S D Fosså, et al.
Pageof 52